Identification | |
---|---|
Name | 2-{[4-(4-pyridin-4-yl-1H-pyrazol-3-yl)phenoxy]methyl}quinoline |
Accession Number | DB08386 |
Type | small molecule |
Description | Not Available |
Structure |
|
Categories (*) | |
Molecular Weight | 378.4259 |
Groups | experimental |
Monoisotopic Weight | 378.148061218 |
Pharmacology | |
Indication | Not Available |
Mechanism of action | Not Available |
Absorption | Not Available |
Protein binding | Not Available |
Biotransformation | Not Available |
Route of elimination | Not Available |
Toxicity | Not Available |
Affected organisms | Not Available |
Interactions | |
Drug Interactions | Not Available |
Food Interactions | Not Available |
cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | |
---|---|
Name | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A |
Gene Name | PDE10A |
Pharmacological action | unknown |
Actions | Not Available |
References |
|
DTHybrid score | Not Available |
Id | Partner name | Gene Name | Score |
---|---|---|---|
541 | cAMP-specific 3',5'-cyclic phosphodiesterase 4B | PDE4B | 0.0564 |
1787 | Nuclear factor NF-kappa-B p105 subunit | NFKB1 | 0.0422 |
1971 | cAMP-specific 3',5'-cyclic phosphodiesterase 4A | PDE4A | 0.0416 |
3806 | cGMP-dependent 3',5'-cyclic phosphodiesterase | PDE2A | 0.0402 |
7 | Nitric oxide synthase, inducible | NOS2 | 0.0288 |
485 | cGMP-inhibited 3',5'-cyclic phosphodiesterase A | PDE3A | 0.0249 |
20 | Prostaglandin G/H synthase 1 | PTGS1 | 0.0198 |
204 | cGMP-specific 3',5'-cyclic phosphodiesterase | PDE5A | 0.0188 |
3957 | Adenosine deaminase | ADA | 0.0176 |
6136 | Multidrug resistance-associated protein 5 | ABCC5 | 0.0152 |
2164 | Multidrug resistance-associated protein 4 | ABCC4 | 0.0128 |
4512 | Cytochrome P450 3A4 | CYP3A4 | 0.0109 |
1588 | Multidrug resistance protein 1 | ABCB1 | 0.0089 |